Inhibition of cellular proliferation by the natural peptides dolastatin 10 and dolastatin 15
Steube, K.G.; Quentmeier, H.; Pettit, G.R.; Pietsch, T.; Brauer, S.; Grunicke, D.; Gignac, S.M.; Drexler, H.G.
Abraham, N G, Konwalinka, G, Marks, P, Sachs, L, Tavassoli, M Molecular biology of haematopoiesis, Vol 2: 567-573
1992
Accession: 031945593
PDF emailed within 1 workday: $29.90
Related References
Steube, K.G.; Grunicke, D.; Pietsch, T.; Gignac, S.M.; Pettit, G.R.; Drexler, H.G. 1992: Dolastatin 10 and dolastatin 15: effects of two natural peptides on growth and differentiation of leukemia cells Leukemia 6(10): 1048-1053Pettit, G.R.; Xu, J.P.ng 2001: Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 Official Gazette of the United States Patent and Trademark Office Patents 1246(5)
Winterhalter, B.R.; Berger, D.P.; Pettit, G.R.; Fiebig, H.H. 1991: Cytotoxicity of dolastatin 10 dolastatin 15 and dolastatin k333 human tumor xenografts in vitro Proceedings of the American Association for Cancer Research Annual Meeting 32: 402
Alcaro, S.; Marino, T.; Ortuso, F.; Russo, N. 2006: Conformational behavior of antineoplastic peptides Dolastatin 10 and Dolastatin 15 from Monte Carlo and molecular dynamics simulations International Journal of Quantum Chemistry 107(2): 318-325
Poncet, J.; Busquet, M.; Roux, F.; Pierré, A.; Atassi, G.; Jouin, P. 1998: Synthesis and biological activity of chimeric structures derived from the cytotoxic natural compounds dolastatin 10 and dolastatin 15 Journal of Medicinal Chemistry 41(9): 1524-1530
Quentmeier, H.; Brauer, S.; Pettit, G.R.; Drexler, H.G. 1992: Cytostatic effects of dolastatin 10 and dolastatin 15 on human leukemia cell lines Leukemia and Lymphoma 6(3): 245-250
Galéotti, N.; Poncet, J.; Jouin, P. 2002: Post-Source Decay Analysis of Dolastatin 10 and Dolastatin 15 by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry European Journal of Mass Spectrometry 8(4): 311-321
Fennell, B.J.; Carolan, S.; Pettit, G.R.; Bell, A. 2003: Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum Journal of Antimicrobial ChemoTherapy 51(4): 833-841
Pettit, G.R.; Srirangam, J.K.; Williams, M.D.; Durkin, K.P.M.; Barlozzari, T.; Kling, A.; Janssen, B.; Haupt, A. 2001: Dolastatin peptides Official Gazette of the United States Patent and Trademark Office Patents 1252(4)
Roux, F.; Maugras, I.; Poncet, J.; Niel, G.; Jouin, P. 1994: Synthesis of dolastatin 10 and -dolastatin 10 Tetrahedron 50(18): 5345-5360
Mitchell, S.S.; Faulkner, D.J.; Rubins, K.; Bushman, F.D. 2000: Dolastatin 3 and Two Novel Cyclic Peptides from a Palauan Collection of Lyngbya m ajuscula Journal of Natural Products 63(2): 279-282
Mitchell, S.S.; Faulkner, D.J.; Rubins, K.; Bushman, F.D. 2000: Dolastatin 3 and two novel cyclic peptides from a palauan collection of Lyngbya majuscula Journal of Natural Products 63(2): 279-282
Pettit, G.R.; Sing, S.B.; Hogan, F.; Lloyd Williams, P.; Herald, D.L.; Burkett, D.D.; Clewlow, P.J. 1989: The absolute configuration and synthesis of natural levo dolastatin 10 Journal of the American Chemical Society 111(14): 5463-5465
Pettit, G.R.; Herald, D.L.; Singh, S.B.; Thornton, T.J.; Mullaney, J.T. 1991: Antineoplastic agents 220 synthesis of natural levo dolastatin 15 Journal of the American Chemical Society 113(17): 6692-6693
Sone, H.; Shibata, T.; Fujita, T.; Ojika, M.; Yamada, K. 1996: Dolastatin H and Isodolastatin H, Potent Cytotoxic Peptides from the Sea Hare Dolabella auricularia: Isolation, Stereostructures, and Synthesis Journal of the American Chemical Society 118(8): 1874-1880
Newman, R.A.; Fuentes, A.; Covey, J.M.; Benvenuto, J.A. 1994: Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128) Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(3): 428-432
Verdier Pinard, P.; Bai, R.; Hamel, E. 1998: Retention of dolastatin 10 by cellular tubulin Basis for the higher potency of peptide-like antimitotic agents Molecular Biology of the Cell 9(Suppl ): 152A
Bai, R.; Friedman, S.J.; Pettit, G.R.; Hamel, E. 1992: Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules Biochemical Pharmacology 43(12): 2637-2645
Li, Y.; Kobayashi, H.; Hashimoto, Y.; Shirai, R.; Hirata, A.; Hayashi, K.; Hamada, Y.; Shioiri, T.; Iwasaki, S. 1994: Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding Chemico-Biological Interactions 93(3): 175-183
Edler, M.C.; Fernandez, A.M.; Lassota, P.; Ireland, C.M.; Barrows, L.R. 2002: Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10 Biochemical Pharmacology 63(4): 707-715